(SYM) Symbotic - Overview
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NASDAQ (USA) | Market Cap: 30.367m USD | Total Return: 134.6% in 12m
Stock
Warehouse Automation, Robotics, Software, Integration, Supply Chain
Total Rating 50
Risk 44
Buy Signal -1.76
Market Cap:
30,367m
Avg Trading Vol: 60.9M USD
Avg Trading Vol: 60.9M USD
ATR:
5.89%
Peers RS (IBD): 74.4
Peers RS (IBD): 74.4
Risk 5d forecast
Volatility82.2%
Rel. Tail Risk-10.2%
Reward TTM
Sharpe Ratio1.33
Alpha93.89
Character TTM
Beta2.629
Beta Downside2.863
Drawdowns 3y
Max DD72.46%
CAGR/Max DD0.36
EPS (Earnings per Share)
EPS CAGR: 9.17%
EPS Trend: 55.5%
EPS Trend: 55.5%
Last SUE: -0.55
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 65.02%
Rev. Trend: 91.7%
Rev. Trend: 91.7%
Last SUE: 0.29
Qual. Beats: 0
Qual. Beats: 0
Risks
Technicals:
volatile
Description: SYM Symbotic
March 04, 2026
Symbotic Inc. (NASDAQ: SYM) is an automation technology company based in Wilmington, Massachusetts.
The company specializes in warehouse automation, developing technologies to improve operational efficiency. This includes automating the handling of pallets, cases, and individual items. Warehouse automation is a growing sector, driven by increasing e-commerce demand and labor shortages.
Symbotics systems focus on enhancing supply chain front-end operations. This business model offers robotics-as-a-service or direct sales of integrated automation solutions.
For more detailed financial analysis, consider exploring ValueRay.
- Warehouse automation demand fuels recurring revenue growth
- Robotics and AI innovation drives competitive advantage
- Supply chain disruptions increase automation adoption
- Large enterprise partnerships secure significant revenue streams
- Labor shortages accelerate warehouse automation investments
Piotroski VR‑10 (Strict, 0-10)
3.5
| Net Income: -10.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA 18.56 > 1.0 |
| NWC/Revenue: 28.22% < 20% (prev 13.66%; Δ 14.56% < -1%) |
| CFO/TA 0.29 > 3% & CFO 853.5m > Net Income -10.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.9m) vs 12m ago 20.52% < -2% |
| Gross Margin: 19.21% > 18% (prev 0.15%; Δ 1.91k% > 0.5%) |
| Asset Turnover: 101.5% > 50% (prev 111.6%; Δ -10.12% > 0%) |
| Interest Coverage Ratio: -12.58 > 6 (EBITDA TTM -8.90m / Interest Expense TTM 4.44m) |
Altman Z''
-0.82
| A: 0.23 (Total Current Assets 2.46b - Total Current Liabilities 1.78b) / Total Assets 2.99b |
| B: -0.44 (Retained Earnings -1.33b / Total Assets 2.99b) |
| C: -0.02 (EBIT TTM -55.9m / Avg Total Assets 2.35b) |
| D: -0.66 (Book Value of Equity -1.33b / Total Liabilities 2.03b) |
| Altman-Z'' Score: -0.82 = CCC |
Beneish M
-3.14
| DSRI: 0.80 (Receivables 357.2m/357.7m, Revenue 2.39b/1.91b) |
| GMI: 0.80 (GM 19.21% / 15.41%) |
| AQI: 1.58 (AQ_t 0.14 / AQ_t-1 0.09) |
| SGI: 1.25 (Revenue 2.39b / 1.91b) |
| TATA: -0.29 (NI -10.9m - CFO 853.5m) / TA 2.99b) |
| Beneish M-Score: -3.14 (Cap -4..+1) = AA |
What is the price of SYM shares?
As of March 31, 2026, the stock is trading at USD 47.41 with a total of 1,166,088 shares traded.
Over the past week, the price has changed by -9.87%, over one month by -13.45%, over three months by -21.34% and over the past year by +134.59%.
Over the past week, the price has changed by -9.87%, over one month by -13.45%, over three months by -21.34% and over the past year by +134.59%.
Is SYM a buy, sell or hold?
Symbotic has received a consensus analysts rating of 3.84.
Therefore, it is recommended to buy SYM.
- StrongBuy: 8
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the SYM price?
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 64.1 | 35.1% |
| Analysts Target Price | 64.1 | 35.1% |
SYM Fundamental Data Overview
March 31, 2026
P/E Forward = 142.8571 P/S = 12.7046
P/B = 9.4953
P/EG = 4.7733
Revenue TTM = 2.39b USD
EBIT TTM = -55.9m USD
EBITDA TTM = -8.90m USD
Long Term Debt = 43.9m USD (estimated: total debt 52.0m - short term 8.07m)
Short Term Debt = 8.07m USD (from shortTermDebt, last quarter)
Debt = 52.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.82b USD (from netDebt column, last quarter)
Enterprise Value = 28.60b USD (30.37b + Debt 52.0m - CCE 1.82b)
Interest Coverage Ratio = -12.58 (Ebit TTM -55.9m / Interest Expense TTM 4.44m)
EV/FCF = 36.68x (Enterprise Value 28.60b / FCF TTM 779.7m)
FCF Yield = 2.73% (FCF TTM 779.7m / Enterprise Value 28.60b)
FCF Margin = 32.62% (FCF TTM 779.7m / Revenue TTM 2.39b)
Net Margin = -0.45% (Net Income TTM -10.9m / Revenue TTM 2.39b)
Gross Margin = 19.21% ((Revenue TTM 2.39b - Cost of Revenue TTM 1.93b) / Revenue TTM)
Gross Margin QoQ = 20.04% (prev 20.55%)
Tobins Q-Ratio = 9.55 (Enterprise Value 28.60b / Total Assets 2.99b)
Interest Expense / Debt = 219.8% (Interest Expense 114.2m / Debt 52.0m)
Taxrate = 4.40% (615k / 14.0m)
NOPAT = -53.4m (EBIT -55.9m * (1 - 4.40%)) [loss with tax shield]
Current Ratio = 1.38 (Total Current Assets 2.46b / Total Current Liabilities 1.78b)
Debt / Equity = 0.08 (Debt 52.0m / totalStockholderEquity, last quarter 663.8m)
Debt / EBITDA = 204.4 (negative EBITDA) (Net Debt -1.82b / EBITDA -8.90m)
Debt / FCF = -2.33 (Net Debt -1.82b / FCF TTM 779.7m)
Total Stockholder Equity = 325.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.46% (Net Income -10.9m / Total Assets 2.99b)
RoE = -3.34% (Net Income TTM -10.9m / Total Stockholder Equity 325.3m)
RoCE = -15.13% (EBIT -55.9m / Capital Employed (Equity 325.3m + L.T.Debt 43.9m))
RoIC = -16.42% (negative operating profit) (NOPAT -53.4m / Invested Capital 325.3m)
WACC = 15.20% (E(30.37b)/V(30.42b) * Re(15.23%) + (debt cost/tax rate unavailable))
Discount Rate = 15.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 23.88%
[DCF] Terminal Value 45.48% ; FCFF base≈519.2m ; Y1≈340.9m ; Y5≈155.9m
[DCF] Fair Price = 25.80 (EV 1.43b - Net Debt -1.82b = Equity 3.24b / Shares 125.8m; r=15.20% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 55.52 | EPS CAGR: 9.17% | SUE: -0.55 | # QB: 0
Revenue Correlation: 91.66 | Revenue CAGR: 65.02% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.12 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=9
EPS current Year (2026-09-30): EPS=0.50 | Chg7d=-0.001 | Chg30d=-0.001 | Revisions Net=-1 | Growth EPS=-74.6% | Growth Revenue=+23.2%
EPS next Year (2027-09-30): EPS=0.75 | Chg7d=-0.000 | Chg30d=-0.000 | Revisions Net=-1 | Growth EPS=+49.8% | Growth Revenue=+28.9%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)